Sign Up to like & get
recommendations!
0
Published in 2024 at "Frontiers in Neuroscience"
DOI: 10.3389/fnins.2024.1389096
Abstract: Introduction Both ketamine (KET) and medial prefrontal cortex (mPFC) deep brain stimulation (DBS) are emerging therapies for treatment-resistant depression, yet our understanding of their electrophysiological mechanisms and biomarkers is incomplete. This study investigates aperiodic and…
read more here.
Keywords:
treatment;
behavioral effects;
mpfc dbs;
sample entropy ... See more keywords